OSR Health (OSRHW) EBT (2022 - 2026)
OSR Health (OSRHW) posted EBT of -$3.9 million for Q1 2026, up 49.62% sequentially from -$7.8 million in Q4 2025, and up 65.6% YoY from -$2.4 million in Q1 2025.
OSR Health (OSRHW) EBT (2022 - 2026) Analysis & Trends
OSR Health has reported EBT for 5 years, with the latest figure at -$3.9 million in Q1 2026.
- Quarterly EBT rose 65.6% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.4 million (down 7.45% YoY) and the FY2025 annual result came in at -$28.9 million, down 142.91% from the prior year.
- EBT advanced to -$3.9 million in Q1 2026 per OSRHW's latest filing, from -$7.8 million in the prior quarter.
- Over five years, EBT peaked at $530029.0 in Q2 2023 and troughed at -$11.4 million in Q1 2025.
- A 5-year average of -$2.7 million and a median of -$2.5 million in 2024 frame the typical range for EBT.
- The sharpest annual moves came in 2023 and 2024: EBT surged 53746.66% in 2023, then plunged 2777.08% in 2024.
- Over 5 years, EBT stood at -$14252.0 in 2022, then surged by 569.18% to $66868.0 in 2023, then slumped by 2777.08% to -$1.8 million in 2024, then sank by 334.64% to -$7.8 million in 2025, then surged by 49.62% to -$3.9 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$3.9 million, -$7.8 million, and -$4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.85 Bn | 131.00 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 62.94 Bn | 57.75 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 55.51 Bn | 50.37 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.46 Bn | 36.36 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.40 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 27.42 Bn | 9.03 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Royalty Pharma | 27.15 Bn | 26.31 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | -1.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.92 Mn |
| Dec 31, 2025 | -7.78 Mn |
| Sep 30, 2025 | -4.49 Mn |
| Jun 30, 2025 | -5.23 Mn |
| Mar 31, 2025 | -11.39 Mn |
| Dec 31, 2024 | -1.79 Mn |
| Sep 30, 2024 | -3.50 Mn |
| Jun 30, 2024 | -3.25 Mn |
| Mar 31, 2024 | -3.36 Mn |
| Dec 31, 2023 | 66,868.00 |
| Sep 30, 2023 | 208,068.00 |
| Jun 30, 2023 | 530,029.00 |
| Mar 31, 2023 | 139,626.00 |
| Dec 31, 2022 | -14,252.00 |
| Sep 30, 2022 | -20,022.00 |
| Jun 30, 2022 | -988.00 |